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ABSTRACT
Aims: To assess the therapeutic effect of curcumin supplementation in modulating the
expression of NF-κB in the joints of collagen-induced arthritis (CIA) rats.
Place and Duration of Study: Department of Postgraduate Studies and Research,
International Medical University, between July 2011 and May 2012.
Methodology: Arthritis was induced in each group of Dark Agouti (DA) rats, by
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intradermal injection with collagen emulsified in complete Freund’s adjuvant. Treatment
groups which were induced with CIA were treated with: 500 mg/kg curcumin; 1000 mg/kg
curcumin; 2000 mg/kg curcumin; 25 mg/kg aspirin. Combination treatment groups which
were induced with CIA were treated with: 500 mg/kg curcumin and 25 mg/kg aspirin; 1000
mg/kg curcumin and 25 mg/kg aspirin; 2000 mg/kg curcumin and 25 mg/kg aspirin from
day 25 to 38. Efficacy was assessed based on ability to reduce paw oedema,
histopathological changes, NF-κB expression, serum tumour necrosis factor alpha (TNF-
α), interleukin 1-beta (IL-1β) and gluthathione peroxidase (GPx) levels.
Results: Based on histopathological study, immunohistochemical scoring of NF-κB and
ELISA analysis of TNF-α, IL-1β and GPx levels, our study found that curcumin given after
arthritis in high doses, shows effects of healing and this results were comparable to
positive control group, which is the arthritic group treated with 25 mg/kg aspirin. Curcumin
given in combination with aspirin, showed better reduction in pathology in arthritic group
compared to positive control group, especially with higher doses of curcumin.
Conclusion: Curcumin was effective in reducing inflammatory changes seen in CIA joints
which were proved through histopathological, immunohistochemical and biochemical
analysis, however only at high doses.
Keywords: Curcumin; nuclear factor kappa B; collagen-induced arthritis; rheumatoid arthritis;
gluthathione peroxidase; tumour necrosis factor alpha; interleukin 1-beta.
1. INTRODUCTION
Curcumin, also known as diferuloylmethane, is a natural compound and principal
curcuminoid of turmeric has been used in Indian Ayurvedic medicine for various diseases
and ailments, besides culinary and textile use due to its characteristic yellow colour [1,2].
There are overwhelming evidences on various properties of curcumin. The widely studied
properties are anti-inflammatory, antioxidant and anticancer [2]. Thus, it has a potential
against various inflammatory diseases, malignancy, allergies and other chronic illnesses.
Curcumin has been extensively studied for its anti-inflammatory properties, and discovery of
various pathways on how curcumin exert this effect have been found [3–6]. One of them is
through the inhibition of nuclear factor kappa B (NF-κB), transcription factor involved in
inflammation [7].
Nuclear factor kappa B (NF-κB) transcription factors are  a family of structurally related
eukaryotic transcription factors that promote the expression of well over 150 genes involved
in a variety of cellular process [8]. Numerous studies have reported that the NF-κB proteins
have diverse roles in B-cell development, proliferation, and effector functions, as well as
proliferation of T-cell [9]. Synovial tissue, both human and several animal models of
rheumatoid arthritis (RA0 have been shown to ubiquitously express NF-κB [10,11]. One such
animal model is collagen-induced arthritis (CIA).
Rheumatoid arthritis is one of the oldest known afflictions to mankind [12] and also the
commonest form of chronic polyarthritis [13]. It is characterised as chronic, systemic
inflammatory disorder that mainly attacks the joints, in addition to various other tissues and
organs such as skin, blood vessels, heart, lungs and muscles [14]. A systematic review
conducted in 2005 based on the 1987 American College of Rheumatology Criteria revealed
that estimated prevalence of RA worldwide is between 0.2% and 1.2% [15]. Population-
based studies on epidemiology of RA are limited especially in the developing countries.
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However, available evidence suggests that incidence of RA is skewing towards elderly age
of onset and the incidence in women is on the rise. The mortality rate for the elderly
population with RA is on the rise likely due to multi systemic manidestation of RA [16]. To
date, the exact cause of RA has not been demonstrated. Studies have shown that the
aetiology is multifactorial, which takes genetic factors [17] and environmental factors [18,19].
There is no cure for RA. Current treatment options focus improving the quality of life of a RA
patient. Disease modifying anti-rheumatic drugs (DMARDs), biologics and non-steroidal anti-
inflammatory drugs (NSAIDs) are the frequently used therapeutics for the treatment of RA
[20]. In spite of variety of treatment options available, a need for a safer and more efficient
drug is still there. This is mainly due to the financial burden and side effects associated with
current therapeutic option. Hence, the spotlight is being diverted toward natural compounds,
which aid the boost of the “nutraceutical revolution”.
NF-κB plays a substantial role in rheumatoid arthritis and has been under the spotlight as a
new potential therapeutic target for the treatment of RA [11,21]. Thus, we aim to assess the
therapeutic effect of curcumin supplementation in modulating the expression of NF-κB in the
joints of CIA rats.
2. MATERIALS AND METHODS
2.1 Experimental Animals
Female, Dark Agouti rats, were obtained at 6-10 weeks old from Institute of Medical
Research (IMR), Malaysia and were acclimatized and maintained in Laboratory Animal
House, International Medical University (IMU) under specific pathogen-free conditions. Each
treatment group consisted of 6 rats.
2.2 Development of CIA
Collagen from chicken sternal cartilage Type II, Complete Freund’s Adjuvant (CFA), Acetic
Acid 99.8% was purchased from Sigma Aldrich, USA. Collagen induced arthritis was
developed in the rats according to the protocol described by Brand et al. [22]. The type II
collagen was reconstituted in 5 ml of 0.1M cold acetic acid and was added to the Complete
Freund’s Adjuvant (CFA) at a ratio of 1:1. The mixture was later homogenised for
approximately 20 minutes at 4°C. Approximately 0.2 – 0.4 ml emulsion was then injected
intradermally at the rat’s base of tail under general anaesthesia using diethyl ether. This
amount the collagen-CFA emulsion injected was adjusted to the body weight of the rat on
day 1 of arthritis induction. The optimum concentration of emulsion to be injected
was previously determined through a pilot study conducted in International Medical
University [23].
2.3 Preparation and Administration of Treatments
Curcumin (>95%) was purchased from Natural Remedies, India, ≥99% crystalline
Acetylsalicylic acid from Sigma Aldrich, USA. Curcumin was prepared in a standard vehicle
of 0.5 – 0.7 ml 100% olive oil. The amount administered was at concentrations of 500 mg/kg,
1000 mg/kg, 2000 mg/kg based on the weight of the rat at day 25 for arthritic groups. This
dosage was selected based on previous established works [5]. As curcumin was delivered
by oral gavage using a gavage tube, direct entry into the gastrointestinal surface was
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ensured. Moreover, the gavage was done on empty stomach before the actual feeding,
hence ensuring optimum absorption without much wastage. Body weight is measured every
4 days and the dosage is changed accordingly for each rat during the treatment period.
Appropriate quantities of curcumin were added to falcon tubes containing olive oil and
thoroughly mixed using a sonicator ensuring both oil particles have combined to an even
mixture. The compound was stored wrapped in aluminum foil, as it is light sensitive.
Treatment was administered as oral supplementation daily using syringes without needle
from day 25 to day 38 for 3 arthritic groups at the aforementioned concentrations
respectively. Aspirin was similarly dissolved in water at a concentration of 3 mg/ml. Each rat
received a dosage 25 mg/kg aspirin based on the weight at day 25 for arthritic group daily for
14 days. Body weight is measured every 4 days and the dosage is changed accordingly for
each rat during the treatment period. Combination treatments were also administered to
three arthritic groups; 500 mg/kg curcumin and 25 mg/kg aspirin; 1000 mg/kg curcumin and
25 mg/kg aspirin; 2000 mg/kg curcumin and 25 mg/kg aspirin from day 25 to 38. One non-
induced group received only 0.5ml olive oil from day 25 to 38, and one arthritic group
received 25 mg/kg aspirin, which were used as negative and positive control group.
2.4 Histological Examination
The knee joints of the rats were collected on day 39 of experimental cycle and were fixed in
10% formalin, decalcified, trimmed, and embedded. After sectioning, the slides were stained
using haematoxylin and eosin staining. The slides were scored by a qualified pathologist
based on these criteria; oedema, cellular infiltration, joint space, synovial
hyperplasia, fibrosis and erosion (see Table 1). This grading system was developed by a
previous study [24].
2.5 Immunohistochemistry
The degree of inflammation in the rats was assessed using NF-κB levels in the knee joints.
Rabbit polyclonal antibody to NF-κB p65 were purchased from ABCAM, UK. It was utilized to
assess and grade the level of NF-κB in the knee joints through immunohistochemistry
Table 1.
2.6 Cytokines (TNF-α and IL-1β) and Gluthathione Peroxidase Levels
On the last day of the experimental cycle (day 39), blood samples were collected from the
animals. After anesthetization with ether, approximately 3-5 ml of blood was obtained from
each rat through cardiac puncture, resulting in its death. Tumour Necrosis Factor Alpha
(TNF-α) and Interleukin – 1 Beta (IL-1β) levels were quantified using the rat TNF-alpha
Platinum ELISA kit (eBioscience, USA) and rat IL-1 beta Tissue Culture ELISA Ready-SET-
Go!® kit (Cayman Chemical, USA) respectively. Gluthathione Peroxidase assay kit (Cayman
Chemical, USA) was used to quantify the Gluthathione Peroxidase (GPx) levels. All the
procedures were followed according to the respective manufacturer’s protocol.
2.7 Statistical Analysis
All data was analysed using SPSS v.18 (SPSS Inc, Chicago, IL, USA). Mann Whitney U test
for nonparametric data was used to analyse the arthritic scores and NF-κB expression. Data
from ELISA was analysed using one-way ANOVA followed by Tukey’s test. For all the tests,
p = 0.05 was considered to be significant.
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3. RESULTS AND DISCUSSION
3.1 Histopathological Analysis
Fig. 1 The histological change was scored in the knee of normal and CIA rats. A) Normal,
wide joint space (red arrow) and presence of healthy cartilage (blue arrow) is seen in the
non-induced + vehicle group (H &E, 200x). B) Synovial hyperplasia (blue arrow),
characteristic finding in RA is seen in arthritis + vehicle group (H&E, 200x). C) Synovial
hyperplasia (blue arrow) seeping into the joint space is seen in this arthritis + 500 mg/kg
curcumin group (H&E, 200x). D) Low level of inflammatory cells (blue arrow) and granulation
tissue is seen in this arthritis + 25 mg/kg aspirin indicative of tissue healing (H&E, 200x). E)
Presence of fresh cartilage proliferation (blue arrow) is found in this arthritis + 500 mg/kg
curcumin + 25 mg/kg aspirin group (H&E, 200x). F) A healthy looking joint is shown with no
signs of inflammation in the arthritis + 2000 mg/kg curcumin + 25 mg/kg aspirin group (H&E,
100x).
One day following the induction of CIA, the physical activity level of the rats decreased. On
day 7 after induction, the swelling of the knee joint started and reached its peak on day 21.
The rats started to limp or drag both its hind paws while moving by day 21. On histological
examination of the knee joint, the non-induced group (vehicle) exhibited no signs of
inflammatory changes. However, the arthritis (vehicle) and arthritis + 500 mg/kg curcumin
group exhibited all signs of inflammation (oedema, inflammatory cell infiltration, joint space
narrowing, snynovial hyperplasia, fibrosis and erosion). Similar findings were found in
arthritis (vehicle) group (p>0.05). Interestingly, arthritis + 1000 mg/kg curcumin, arthritis +
2000 mg/kg curcumin and arthritis + 25 mg/kg aspirin all exhibited reduced inflammatory
features and signs of healing (p<0.01). Combination treatment groups which are arthritis +
500 mg/kg curcumin + 25 mg/kg aspirin, arthritis + 1000 mg/kg curcumin + 25 mg/kg aspirin
and arthritis + 2000 mg/kg curcumin + 25 mg/kg aspirin group showed reduced inflammation
and healing when compared to arthritis (vehicle) group (p<0.05). When curcumin alone
treated groups (500 mg/kg, 1000 mg/kg, 2000 mg/kg) and combination treatment groups
compared with arthritis + 25 mg/kg aspirin group, there were no significant difference found
in terms of inflammatory features (p>0.05) on histology examination.
3.2 NF-κB Immunohistochemistry
Fig. 2 immunohistochemistry for NF-κB p65 antibody was performed on the knee joints,
which is stained brown on the tissue sections. A) A scattered expression of NF-κB
expression is seen in the non-induced (vehicle) group (IHC, 200x). B) An extensive
expression of NF-κB is seen in the arthritis (vehicle) group (IHC, 200x) (blue arrows) C)
Arthritis + 1000 mg/kg curcumin groups exhibits a moderate level of NF-κB expression
(IHC,200x) (blue arrows) D) Low level of expression is seen in arthritis + 2000 mg/kg
curcumin group (IHC, 200x). E) & F) Mild expression of NF-κB is seen in both arthritis + 25
mg/kg aspirin and arthritis + 2000 mg/kg curcumin + 25 mg/kg aspirin group (IHC, 200x).
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Fig. 1. The histological change was scored in the knee of normal and CIA rats. A)
Normal, wide joint space (red arrow) and presence of healthy cartilage (blue arrow) is
seen in the non-induced + vehicle group (H &E, 200x). B) Synovial hyperplasia (blue
arrow), characteristic finding in RA is seen in arthritis + vehicle group (H&E, 200x). C)
Synovial hyperplasia (blue arrow) seeping into the joint space is seen in this arthritis
+ 500 mg/kg curcumin group (H&E, 200x). D) Low level of inflammatory cells (blue
arrow) and granulation tissue is seen in this arthritis + 25 mg/kg aspirin indicative of
tissue healing (H&E, 200x). E) Presence of fresh cartilage proliferation (blue arrow) is
found in this arthritis + 500 mg/kg curcumin + 25 mg/kg aspirin group (H&E, 200x). F)
A healthy looking joint is shown with no signs of inflammation in the arthritis + 2000
mg/kg curcumin + 25 mg/kg aspirin group (H&E, 100x)
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Fig. 2. Immunohistochemistry for NF-κB p65 antibody was performed on the knee
joints, which is stained brown on the tissue sections. A) A scattered expression of
NF-κB expression is seen in the non-induced ( vehicle) group (IHC, 200x). B) An
extensive expression of NF-κB is seen in the arthritis (vehicle) group (IHC, 200x) (blue
arrows) C) Arthritis + 1000 mg/kg curcumin groups exhibits a moderate level of NF-κB
expression (IHC,200x) (blue arrows)  D) Low level of expression is seen in arthritis +
2000 mg/kg curcumin group (IHC, 200x). E) & F) Mild expression of NF-κB is seen in
both arthritis + 25 mg/kg aspirin and arthritis + 2000 mg/kg curcumin + 25 mg/kg
aspirin group (IHC, 200x).
As seen in Fig. 2, the NF-κB expression in the arthritis (vehicle) group was significantly
higher than the non-induced (vehicle) group (p<0.01). Significant reduction in NF-κB
expression was observed in arthritis + 25 mg/kg aspirin (p<0.01), arthritis + 1000 mg/kg
British Journal of Medicine & Medical Research, 4(15): 2940-2954, 2014
2947
curcumin (p<0.01) and arthritis + 2000 mg/kg curcumin (p<0.01) groups when compared
with arthritis (vehicle) group. Significant reduction of NF-κB was found in all the combination
treatment groups when compared to the arthritis (vehicle) group (p<0.01). Comparison were
also made between arthritis + 25 mg/kg aspirin and all the combination treatment groups,
which revealed good correlation (p<0.01) except in arthritis + 500 mg/kg curcumin + 25
mg/kg aspirin group (p<0.05).
3.3 TNF-α and IL-1β Levels
In comparison with non-induced (vehicle) groups, TNF-α level was significantly higher in
arthritis (vehicle) group (p=0.05). This level continued to decrease until the level was almost
similar in arthritis + 2000 mg/kg curcumin to the level in the non-induced (vehicle) group.
Interestingly, the TNF-α levels in the arthritis + 500 mg/kg curcumin + 25 mg/kg aspirin and
arthritis + 1000 mg/kg curcumin + 25 mg/kg aspirin were higher than arthritis and 25 mg/kg
aspirin group (p=0.05). However, the levels were similar between arthritis + 2000 mg/kg
curcumin + 25 mg./kg aspirin and arthritis + 25 mg/kg aspirin group, with no significant
difference
A
A B
C D
Fig. 3. TNF-α and IL-1β Levels
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A very similar pattern was seen in term of IL-1β expression as well. The arthritis (vehicle)
group expressed significantly higher levels of IL-1β compared to non-induced (vehicle) group
(p=0.05). However, only significant reduction of IL-1β levels were only seen in arthritis +
1000 mg/kg curcumin and arthritis + 2000 mg/kg curcumin groups (p=0.05). In the
combination treatment groups, arthritis + 1000 mg/kg curcumin + 25 mg/kg aspirin and
arthritis + 2000 mg/kg curcumin + 25 mg/kg aspirin groups expressed significantly lower
levels of IL-1β levels compared to the arthritis + 25 mg/kg aspirin group (p=0.05).
3.4 Gluthathione Peroxidase Activity Level
Gluthathione peroxidase levels was significantly higher in the non-induced (vehicle) group in
comparison to all other groups (p=0.05). Nonetheless, arthritis + 500 mg/kg curcumin,
arthritis + 1000 mg/kg curcumin and arthritis + 2000 mg/kg curcumin showed significant
increase in GPx level when compared to the arthritis (vehicle) group (p=0.05). Similarly, all
the combination treatments groups showed significant increase when compared to the same
group (p=0.05). Only arthritis + 2000 mg/kg curcumin + 25 mg/kg aspirin group showed
significant increase in GPx level when compared to arthritis + 25 mg/kg aspirin group
(p=0.05).
This study was done to observe the effect of curcumin in arthritis and also its relationship
with the function of NF-κB. Curcumin has been widely used as a therapeutic agent in
traditional medicine for several centuries. Scientific studies on role of curcumin in health
related conditions are fairly new in the research world. Much of the research in curcumin has
been focused in areas like, cancer, wound healing, malaria and just to name a few [25].
Effect of curcumin in arthritis has not been studied much except for a few research works
which have highlighted the role of curcumin in arthritis. Mun  et al. demonstrated that oral
administration of curcumin ameliorates type II collagen-induced arthritis in mice. They also
reported that it inhibits the production of matrix metalloproteinase-1 and matrix
mettaloproteinase III production in CIA is mediated through the inhibition of protein kinase
Cδ (PKCδ) and the JNK/c-Jun signaling pathway [26].
Rheumatoid arthritis involves several cytokines in its pathogenesis. However, TNF-α is
considered to be at the apex of of cytokine cascade that lead to pathological changes in RA.
Development of anti TNF-α therapy has been successful in disease remission to a certain
extent [14,15]. Interleukin-1β is another main cytokines that contribute to the disease
progression and therapy against this cytokine has been proven effective [15,16]. Oxidative
damage by free oxygen radical has been associated in the pathobiology of rheumatoid
arthritis. Glutathione peroxidase dependent mechanism is one of the pathway
erythrocyte utilized to scavenge free oxygen radical, in order to minimize the extent of
damage to tissue [17].
On another study conducted by Okamoto et al., similar finding was reported, through
inhibition of Interleukin-17 (IL-17) [27]. Recently, a clinical trial was carried out by Chandran
et al. on the efficacy and safety of curcumin on active rheumatoid arthritis patients, which
was then proven to be more effective than diclofenac sodium, an established anti-
inflammatory. No adverse events was reported [28]. Hence, it is justifiable to study its effect
in management of rheumatoid arthritis [29].
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Fig. 4. Gluthathione Peroxidase Activity Level
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The role of NF-κB in arthritis is an established one. It has proinflammatory properties and is
expected to increase the level of inflammation and hence, would be expected in high
concentration when there is arthritis, whether the arthritis is an active form of disease or
whether there is a certain amount of healing [30]. Therefore, the level of NF-κB would vary
depending on the tissues in the joints in normal, inflammatory, healing, and healed tissue.
Nuclear factor kappa-B in arthritis has been studied extensively, some of which have been
referred to in this study. Yamasaki  et al. proved that NF-κB is highly expressed in synovial
tissue from rheumatoid arthritis patients [31]. Inhibitor of nuclear factor kappa B kinase
(IKKβ) activation, causes the NF-κB translocation into the nucleus to initiate inflammatory
response. This was demonstrated in Lewis rats by Tak et al [32]. To further clarify the role of
NF-κB, Tsuchiya et al., proved that inhibition of translocation of NF-κB to the nucleus
resulted in reduction of cytokines production that is involved in rheumatoid arthritis [33,34].
In the histopathology study, there were no morphological changes in the non-induced +
vehicle group. However, in the arthritis (vehicle) and arthritis + 500 mg/kg curcumin, there
was extensive damage to the joint including oedema, inflammatory cell infiltrates, joint space
narrowing, synovial hyperplasia, fibrosis and bone erosion. This difference was significant
(p<0.05) when compared to the control group.
Observation on the arthritis + 1000 mg/kg curcumin, arthritis + 2000 mg/kg curcumin and all
combination treatment groups and arthritis + 25 mg/kg aspirin showed a significant reduction
in pathology and also areas of healing as suggested by the presence of granulation tissue
which is seen as proliferation of small blood vessels and fibroblast. Our histopathological
changes due to curcumin at higher doses treatment after induction of arthritis were
comparable to studies done. [26,35].
Non-induced group (vehicle) showed nil or scattered expression of NF-κB. Over expression
of NF-κB was seen in arthritis (vehicle) and arthritis + 500 mg/kg curcumin. Arthritis + 1000
mg/kg curcumin, arthritis + 2000 mg/kg curcumin, arthritis + 25 mg/kg aspirin and all
combination treatment groups showed low to moderate expression. Combination group of
1000 mg/kg curcumin and 2000 mg/kg curcumin together 25 mg/kg aspirin, showed
significant result when compared to aspirin treated arthritic group (p<0.05).
In short, inflammatory response was lower at higher doses of curcumin, and it was even
better when given together with aspirin. Several studies have documented inhibition of NF-
κB by curcumin, but only in cell line by Singh et al. [7].
Both TNF-α and IL-1β levels were found to be increased in the arthritis groups and
comparatively decreased in all the treated groups with more prominent reduction observed
as curcumin dosages increased, along with aspirin. It was even more reduced in
combination treatment groups.
Glutathione peroxidase was found to be decreased in the arthritis (vehicle) and arthritis +
500 mg/kg curcumin groups and showed increasing levels in the healing groups and this
were comparable to negative control group. Combination group again showed higher levels
of GPx than aspirin treated arthritic group. These reduction of TNF-α and IL-1β and increase
in GPx level in amelioration of CIA due to treatment were consistent with several other
studies [36,37].
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Based on these findings, curcumin given after arthritis in high doses, shows effects of
healing and this results were comparable to positive control group, which is the arthritic
group treated with 25 mg/kg aspirin. Curcumin given in combination with aspirin, showed
better reduction in pathology in arthritic group compared to positive control group, especially
with higher doses of curcumin.
4. CONCLUSION
In this study, curcumin has been found to have a therapeutic effect in the treatment of CIA in
DA rats, however only at higher doses. The action of curcumin has an inverse proportional
relationship with NF-κB expression as observed in other studies. It also shows that
combination treatment of aspirin and curcumin is beneficial in CIA, which need further
research including clinical trials. This can bring about major changed in the treatment of
rheumatoid arthritis with fewer side effects that is currently through the use of natural
compounds like curcumin.
For future study, this therapeutic effect of curcumin on the expression of NF-κB in CIA may
be reaffirmed by real time polymerase chain reaction (q-PCR) method. In the next level of
animal study, curcumin can be compared to a primary anti-rheumatic drug, such as
methotrexate to further assess its therapeutic efficacy.
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